Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,361 public trials 406 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Active, Not Recruiting

Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin

NCT06640530

Conditions
Advanced Melanoma, Melanoma, Melanoma (Skin), +11 more
Locations
  • Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus
  • Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus
  • Healthcare Institution "Minsk City Clinical Cancer Center" Minsk, Belarus
  • State Institution "Republic Scientific and Practical Centre for Oncology and Medical Radiology Named after N.N.Aleksandrov" Minsk, Belarus
View all 44 locations
View Trial Details
Active, Not Recruiting

A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma

NCT05751928

Conditions
Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +12 more
Locations
  • State Institution "Republican Scientific and Practical Center of Oncology and Medical Radiology named after A.I. N.N. Alexandrov" Lesnoy, Belarus
  • Healthcare Institution "Minsk City Clinical Cancer Center" Minsk, Belarus
  • State Institution "Mogilev Regional Oncological Dispensary" Mogilev, Belarus
  • Healthcare Institution "Vitebsk Regional Clinical Oncology Center" Vitebsk, Belarus
View all 36 locations
View Trial Details
Active, Not Recruiting

A Phase 1/2 Study of BA3071 in Patients With Solid Tumors

NCT05180799

Conditions
Melanoma, NSCLC, Neoplasm Metastasis, +14 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Piedmont West Atlanta, Georgia, United States
  • Northwest Cancer Centers Dyer, Indiana, United States
View Trial Details
Active, Not Recruiting

Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma

NCT02743819

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Mount Sinai Medical Center of Florida Miami Beach, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients

NCT04385732

Conditions
Anxiety Disorders, Anxiety and Fear, Melanoma, +13 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Newcastle Skin Check Newcastle, New South Wales, Australia
  • Dermatology Clinical Trials Unit, Westmead Hospital Sydney, New South Wales, Australia
  • Melanoma Institute Australia Wollstonecraft, New South Wales, Australia
View Trial Details
Active, Not Recruiting

TH1902 in Patients With Advanced Solid Tumors

NCT04706962

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Pennsylvania Cancer Specialists Research Institute Gettysburg, Pennsylvania, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details

Related conditions